Macrogenics (MGNX) Stock Price, Quote & News

Company Profile

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which ha...

Industry: Biotechnology

Sector: Healthcare

Phone: 301 251 5172

Fax: 301 251 5321

Website: www.macrogenics.com

Address:

9704 Medical Center Drive, Rockville, United States

biolover Mar. 20 at 4:32 PM

$MGNX With this fierce repetition from China on all classes of therapeutics. It is enticing to be FIC with descent time lead. That what I like about $MGNX adam9 ADC. Also GI expression ( in these cancers with limited ADC targets .. seen $CTMX trying to mask .. ) , no reported ILD and responses within one year of phase 1 start ( that is remarkable as trial started around this time in 2025 ) Love to be ahead of institutions. Watch your risk.

0 · Reply

WienersOut4RCAT Mar. 20 at 2:54 PM

$ACXP $MGNX $KITT $OPTT

0 · Reply

Budman10 Mar. 19 at 8:15 PM

$MGNX Holding up well considering this shitty market.

0 · Reply

Nanu108 Mar. 19 at 4:45 AM

$MGNX in for 10000 shares.

0 · Reply

FindFunds Mar. 19 at 2:34 AM

$MGNX is it just the economy?

0 · Reply

PSDL75 Mar. 18 at 8:08 PM

$MGNX silly games

0 · Reply

biostocktrader_number_1 Mar. 17 at 8:58 AM

$MGNX think its a good stock

0 · Reply

Sw1ngb0t Mar. 16 at 8:09 PM

$MOBX $EDSA $STAK $RXT $MGNX burn em

0 · Reply

winners3628 Mar. 16 at 5:21 PM

$MGNX instead of chasing ctmx , bought more mgnx

0 · Reply

biolover Mar. 16 at 3:12 PM

$CTMX $VKTX if u missed on CTMX. Look at $MGNX Adam 9 high expression in GI cancers. And company reported responses. Data H2. Trying to stay ahead of data. VKTX still the best derisked asset

0 · Reply

MacroGenics, Inc. (MGNX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mar 9, 2026, 4:01 PM EDT - 12 days ago

MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

Feb 26, 2026, 5:30 PM EST - 23 days ago

MacroGenics to Participate in Upcoming Investor Conferences

Feb 23, 2026, 6:14 PM EST - 26 days ago

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

Nov 25, 2025, 4:05 PM EST - 4 months ago

MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

Nov 12, 2025, 4:01 PM EST - 4 months ago

MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress

Nov 6, 2025, 4:30 PM EST - 4 months ago

MacroGenics to Participate in the Stifel 2025 Healthcare Conference

Sep 2, 2025, 4:30 PM EDT - 7 months ago

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Aug 14, 2025, 4:01 PM EDT - 7 months ago

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

Aug 13, 2025, 4:01 PM EDT - 7 months ago

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

Jun 11, 2025, 6:32 PM EDT - 10 months ago

MacroGenics: Working On That Road To Recovery

Jun 10, 2025, 7:00 AM EDT - 10 months ago

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

Jun 3, 2025, 4:30 PM EDT - 10 months ago

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 13, 2025, 4:01 PM EDT - 11 months ago

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

May 6, 2025, 4:30 PM EDT - 11 months ago

MacroGenics Announces Date of First Quarter 2025 Financial Results

May 1, 2025, 4:30 PM EDT - 11 months ago

MacroGenics to Participate in Upcoming Investor Conference

Mar 20, 2025, 7:09 PM EDT - 1 year ago

MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 7:30 AM EST - 1 year ago

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

Feb 27, 2025, 2:08 PM EST - 1 year ago

MacroGenics: Stacking Up A Lot Of Headwinds

Nov 5, 2024, 7:01 PM EST - 1 year ago

MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript

Nov 5, 2024, 4:01 PM EST - 1 year ago

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Oct 30, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Announces Leadership Transition

Oct 29, 2024, 4:30 PM EDT - 1 year ago

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

Oct 25, 2024, 5:15 PM EDT - 1 year ago

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

Oct 22, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

Sep 24, 2024, 12:57 PM EDT - 1 year ago

Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX

Sep 24, 2024, 10:30 AM EDT - 1 year ago

MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm

Sep 23, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Sep 22, 2024, 11:09 AM EDT - 1 year ago

MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman

Sep 21, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 19, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

Sep 19, 2024, 9:57 AM EDT - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

Sep 19, 2024, 5:45 AM EDT - 1 year ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit - MGNX

Sep 17, 2024, 11:23 AM EDT - 1 year ago

MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Sep 17, 2024, 11:04 AM EDT - 1 year ago

Hospice Dynamix Welcomes Industry Veteran Rob Stoltz as Chief Strategy Officer

Sep 17, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm About A Suit

biolover Mar. 20 at 4:32 PM

0 · Reply

WienersOut4RCAT Mar. 20 at 2:54 PM

$ACXP $MGNX $KITT $OPTT

0 · Reply

Budman10 Mar. 19 at 8:15 PM

$MGNX Holding up well considering this shitty market.

0 · Reply

Nanu108 Mar. 19 at 4:45 AM

$MGNX in for 10000 shares.

0 · Reply

FindFunds Mar. 19 at 2:34 AM

$MGNX is it just the economy?

0 · Reply

PSDL75 Mar. 18 at 8:08 PM

$MGNX silly games

0 · Reply

biostocktrader_number_1 Mar. 17 at 8:58 AM

$MGNX think its a good stock

0 · Reply

Sw1ngb0t Mar. 16 at 8:09 PM

$MOBX $EDSA $STAK $RXT $MGNX burn em

0 · Reply

winners3628 Mar. 16 at 5:21 PM

$MGNX instead of chasing ctmx , bought more mgnx

0 · Reply

biolover Mar. 16 at 3:12 PM

$CTMX $VKTX if u missed on CTMX. Look at $MGNX Adam 9 high expression in GI cancers. And company reported responses. Data H2. Trying to stay ahead of data. VKTX still the best derisked asset

0 · Reply

Sw1ngb0t Mar. 15 at 12:00 AM

$MOBX $STAK $EDSA $EONR $MGNX

0 · Reply

Sw1ngb0t Mar. 13 at 8:30 PM

$MOBX $STAK $EDSA $RXT $MGNX all very similar even if they don't look the same. $STAK with some movement. bulls run next week

0 · Reply

Budman10 Mar. 13 at 8:21 PM

$MGNX need to see what happens end of month

1 · Reply

Budman10 Mar. 13 at 8:18 PM

$MGNX as we know a few institutions sold earlier this year and end of last year. Most likely due to bylaw rules based on stock price. Someone added this past week

0 · Reply

PSDL75 Mar. 13 at 6:04 PM

$CRDF slowly bleeding these out $TMC $MGNX

0 · Reply

Sw1ngb0t Mar. 13 at 11:30 AM

$MOBX $STAK $EDSA $RXT $MGNX

0 · Reply

Sw1ngb0t Mar. 12 at 10:13 PM

$MOBX $STAK $EDSA $RXT $MGNX nothing new today

0 · Reply

Budman10 Mar. 12 at 1:20 PM

$MGNX Barclays call today 10 AM Eastern. I would like to CEO to talk more about the potential milestone payments they can earn this year. Zynyz was approved in Japan in December and just last week in Europe. How much are they inline to earn?

0 · Reply

StockScanners Mar. 12 at 4:13 AM

$MGNX reached 3.54

0 · Reply

Sw1ngb0t Mar. 12 at 1:17 AM

$MOBX $STAK $EDSA $RXT $MGNX

0 · Reply

Budman10 Mar. 11 at 8:08 PM

$MGNX Held up well today.

2 · Reply

Market Cap	195.75M
Revenue (ttm)	149.50M
Net Income (ttm)	-74.62M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-49.91%
Debt to Equity Ratio	0.00

Volume	644,100
Avg Vol	1,137,042
Day's Range	N/A - N/A
Shares Out	63.56M
Stochastic %K	40%
Beta	1.45
Analysts	Sell
Price Target	$3.60